MatthiasHoldhoffMD

PubMed

• Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
  Sachiv Chakravarti, Cathleen C Kuo, Foad Kazemi, Ashley Kang, Calixto-Hope Lucas, Victoria Croog, David Kamson, Karisa C Schreck, Matthias Holdhoff, Chetan Bettegowda,...> ;Journal of Neuro-Oncology. 2024 Mar 15
• Postradiation platinum-etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity.
  Munjapara, V., Bazer, D., Sherief, M., Kamson, D., Ye, X., Komlodi-Pasztor, E., Eberhart, C., Ozer, B., Holdhoff, M.> ;CNS Oncology. 2024 Mar 8
• Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Suscep...
  Lambrecht, S., Liu, D., Kamson, D., Reis, J., Liebig, T., Van Zijl, P., Qin, Q., Dzaye, O., Holdhoff, M., Lin, D.> ;Brain Sciences. 2024 Jan 25
• Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
  Christopher Douville, Samuel Curtis, Mahmoud Summers, Tej D Azad, Jordina Rincon-Torroella, Yuxuan Wang, Austin Mattox, Bracha Avigdor, Jonathan Dudley, Joshua Materi,...> ;Cell Reports. Medicine. 2023 Aug 15
• 1 citations
  Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
  Matthias Holdhoff, M Kelly Nicholas, Richard A Peterson, Stefania Maraka, Li C Liu, James H Fischer, Jeffrey S Wefel, Timothy M Fan, Tracy Vannorsdall, Meredith Russel...> ;Neuro-Oncology Advances. 2023 Jul 19
• 1 citations
  CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatmen...
  Qianqi Huang, Jingpu Wu, Nhat Le, Yiqing Shen, Pengfei Guo, Karisa C Schreck, David Kamson, Lindsay Blair, Hye-Young Heo, Xu Li, Wenbo Li, Haris L Sair, Jaishri O Blak...> ;Magnetic Resonance Imaging. 2023 Oct 1
• 1 citations
  A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.
  Karthik K Ramesh, Vicki Huang, Jeffrey Rosenthal, Eric A Mellon, Mohammed Goryawala, Peter B Barker, Saumya S Gurbani, Anuradha G Trivedi, Alexander S Giuffrida, Eduar...> ;Tomography. 2023 Feb 6
• 32 citations
  NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
  Craig Horbinski, Louis Burt Nabors, Jana Portnow, Joachim Baehring, Ankush Bhatia, Orin Bloch, Steven Brem, Nicholas Butowski, Donald M Cannon, Samuel Chao, Milan G Ch...> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• 11 citations
  Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β.
  Kajal Chaudhry, Ashley Geiger, Ehsan Dowlati, Haili Lang, Danielle K Sohai, Eugene I Hwang, Christopher A Lazarski, Eric Yvon, Matthias Holdhoff, Richard Jones, Barbar...> ;Molecular Therapy. Methods & Clinical Development. 2022 Dec 8
• 7 citations
  Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
  Oana C Danciu, Matthias Holdhoff, Richard A Peterson, James H Fischer, Li C Liu, Heng Wang, Neeta K Venepalli, Rozina Chowdhery, M Kelly Nicholas, Meredith J Russell, ...> ;British Journal of Cancer. 2023 Mar 1
• 1 citations
  BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report.
  Vasu Munjapara, Thatcher Heumann, Karisa C Schreck, John M Gross, Carlos Perez-Heydrich, Sachin K Gujar, Charles G Eberhart, Matthias Holdhoff> ;Case Reports in Oncology. 2022 Oct 7
• Safety of temozolomide use in adult patients with renal dysfunction.
  Kayla Garzio, Kelly McElroy, Stuart Grossman, Matthias Holdhoff, Byram Ozer, Olga Yankulina> ;Journal of Neuro-Oncology. 2022 Sep 1
• 6 citations
  Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Gli...
  Karen Xu, Karthik Ramesh, Vicki Huang, Saumya S Gurbani, James Scott Cordova, Eduard Schreibmann, Brent D Weinberg, Soma Sengupta, Alfredo D Voloschin, Matthias Holdho...> ;Tomography. 2022 Mar 3
• 15 citations
  A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
  Karthik Ramesh, Eric A Mellon, Saumya S Gurbani, Brent D Weinberg, Eduard Schreibmann, Sulaiman A Sheriff, Mohammed Goryawala, Macarena de le Fuente, Bree R Eaton, Jim...> ;Neuro-Oncology Advances. 2022 Jan 27
• 1 citations
  Current and Future Frontiers of Molecularly Defined Oligodendrogliomas.
  Jordina Rincon-Torroella, Maureen Rakovec, Josh Materi, Divyaansh Raj, Tito Vivas-Buitrago, Abel Ferres, William Reyes Serpa, Kristin J Redmond, Matthias Holdhoff, Che...> ;Frontiers in Oncology. 2022 Jan 1
• CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.
  Eitan Halper-Stromberg, Chad M. McCall, Lisa Haley, Ming-Tseh Lin, Samantha L. Vogt, Christopher D. Gocke, James R. Eshleman, Wendy Stevens, Neil A. Martinson, Marta E...> ;Clinical Chemistry. 2021 Nov 1
• 1 citations
  Report of Canonical BCR-ABL1 Fusion in Glioblastoma.
  Ying Pang, Guangyang Yu, Madison Butler, Sivasish Sindiri, Young K. Song, Jun Wei, Xinyu Wen, Hsien-Chao Chou, Martha Quezado, Svetlana Pack, Liqiang Xi, Zied Abdullae...> ;JCO Precision Oncology. 2021 Aug 25
• 32 citations
  Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers.
  , , , , , , , , , , , , , , , , , , , , , > ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 3 citations
  Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary ...
  Cole Sterling, Hua Ling Tsai, Matthias Holdhoff, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Christian B. Gocke, Syed Abbas Ali, Ivan Borrello,...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 6 citations
  IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
  Ellen K. Chang, Matthew A. Smith-Cohn, Benita Tamrazi, Jianling Ji, Mark D. Krieger, Matthias Holdhoff, Charles G. Eberhart, Ashley Margol, Jennifer A. Cotter> ;Brain Pathology. 2021 May 7
• 9 citations
  Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
  Bradley M. Downs, Wanjun Ding, Leslie Cope, Christopher B. Umbricht, Wenge Li, Huihua He, Xiaokang Ke, Matthias Holdhoff, Chetan Bettegowda, Weiping Tao, Saraswati Suk...> ;Clinical Epigenetics. 2021 May 5
• 16 citations
  Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial.
  Gary L. Gallia, Matthias Holdhoff, Henry Brem, Avadhut D. Joshi, Christine L. Hann, Renyuan Bai, Verena Staedtke, Jaishri O. Blakeley, Soma Sengupta, T Che Jarrell, Je...> ;Neuro-Oncology Advances. 2021 Jan 1
• 236 citations
  Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
  Louis B. Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Pete...> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
• 29 citations
  Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
  Matthias Holdhoff, Maciej M. Mrugala, Christian Grommes, Thomas Kaley, Lode J. Swinnen, Carlos Perez-Heydrich, Lakshmi Nayak> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
• 10 citations
  Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies.
  Matthias Holdhoff, Nina D. Wagner-Johnston, Mark Roschewski> ;Oncotargets and Therapy. 2020 Aug 20
• Join now to see all

Journal Articles

• A Multiprotein Supercomplex Controlling Oncogenic Signalling in Lymphoma  
  Maryknoll M Palisoc, Lisa M Rimsza, Stephen M Hewitt, Wyndham H Wilson, Matthias Holdhoff, Fayez Estephan, Nature

Abstracts/Posters

• Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvemen...
  Matthias Holdhoff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019